Riskpilot← Back to searchSign inGet full accessMED KJEMI AS
ASActiveOrg 943568758Drengsrudbekken 9, 1383 AskerWholesale of pharmaceutical and medical goods · NACE 4646Est. 19875 employees
Revenue 2025
NOK 52,4M
-5% vs 2024
EBITDA margin
17.4%
+206% vs 2024
Equity ratio
34.9%
Financial strength
Net profit 2025
NOK 7,1M
+223% vs 2024
| Revenue | NOK 52,4M | -5% |
| EBITDA | NOK 9,1M | +206% |
| Net profit | NOK 7,1M | +223% |
| Total assets | NOK 19,5M | +28% |
| Equity | NOK 6,8M | +19% |
| Employees | 5 | — |
Legal name
MED KJEMI AS
Org number
943568758
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 1987
Share capital
NOK 600 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Produksjons-, handels- og agenturvirksomhet av spesialprodukter og farmasøytiske preparater overfor norske leger, sykehus, helsetjeneste, forskningslaboratorier og apotek, og alt som hermed står i forbindelse, herunder deltagelse med eierandeler i andre selskaper.
Address
Drengsrudbekken 9, 1383 Asker
Phone
+4766764900
Email
firmapost@med-kjemi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 45 555 | 47 286 | 52 551 | 54 910 | 52 404 |
| Staff expenses | −7 165 | −6 554 | −6 725 | −7 199 | −7 863 |
| EBITDA | 2 012 | 950 | 1 096 | 2 981 | 9 109 |
| Depreciation & amort. | −11 | −18 | −12 | −12 | −12 |
| EBIT | 2 002 | 932 | 1 084 | 2 968 | 9 096 |
| Net financials | −38 | −92 | −96 | −135 | 23 |
| Profit before tax | 1 964 | 840 | 988 | 2 833 | 9 119 |
| Tax | 359 | 188 | 220 | 635 | 2 013 |
| Net profit | 1 605 | 652 | 768 | 2 198 | 7 107 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 054 | 14 592 | 16 696 | 15 271 | 19 492 |
| Equity | 4 269 | 4 321 | 4 489 | 5 687 | 6 794 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 785 | 10 271 | 12 207 | 9 584 | 12 699 |
| Total debt | 11 785 | 10 271 | 12 207 | 9 584 | 12 699 |
EBITDA margin
17.4%
This company
15.8%
Market median
+10% vs market
20212025
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
104.6%
This company
18.4%
Market median
+468% vs market
20212025
Net profit margin
13.6%
This company
8.1%
Market median
+68% vs market
20212025
Asset turnover
2.69×
This company
1.12×
Market median
+140% vs market
20212025
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
BE Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (3) | ||
| Chairman | 2023 – 2025 | |
| Board of Directors | 2021 – 2023 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 46% | 46% | 2024 | |
| Company | 46% | 46% | 2024 | |
| Individual | 4% | 4% | 2024 | |
| Individual | 4% | 4% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Med-Hold As
MED KJEMI AS Board members of MED KJEMI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Egil Ludvigsen | Chief Executive Officer | 0 companies |
| Karin Stangeland | Chief Executive Officer | 0 companies |
| Jon Terje Heimdal | Chairman | 0 companies |
| Olaf Jørgen Styrmoe | Board of Directors | 0 companies |
| Bjørn Fredborg Nilsen | Chairman | 0 companies |
| Jens Ragnar Jensen | Chairman | 0 companies |